Effects of indomethacin, cisplatin and Δ12-prostaglandin J2 on growth of oral squamous carcinoma cells

Anticancer Research

Volumn 17, Issue 6 D, 1997, Pages 4399-4402

  El Attar, Tawfik M A ^a   Virji, Adi S ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Oral; Prostaglandins; Squamous carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DELTA12 PROSTAGLANDIN J2; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN;

ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUTH CARCINOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELL SURVIVAL; CISPLATIN; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INDOMETHACIN; PROSTAGLANDIN D2; PROSTAGLANDINS, SYNTHETIC; TONGUE NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0031409306     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Pollard M and Luckert PH: Effect of indomethacin on intestinal tumors induced in rats by acetate derivative of dimethylnitrosamine. Science 214: 558-559, 1981.
2. Narisawa T, Sato M, Tani M, Kudo T, Takahashi T and Goto A: Inhibition of development of methlnitrosourea induced rat colon tumors by indomethacin treatment. Cancer Res 41: 1954-1957, 1981.
3. Rabio CA: Antitumor activity of indomethacin on experimental esophageal tumors. J National Cancer Inst 72: 705-707, 1980.
4. Fulton AM: In vivo effects of indomethacin on the growth of murine mammary tumors. Cancer Res 44: 2416-2420, 1984.
5. Rosenberg B: Fundamental studies with cisplatin: Cancer 55(10): 2303-2316, 1985.
6. Drewinko B, Gottlieb JA: Action of cis-dichloroammine platinum (II) (NSC-119875) at the cellular level. Cancer Chemotherapy Reports-Part 159(4): 769-771, 1975.
7. Parker RJ, Gill I, Tarone R, Vionnet JA, Grunberg S, Muggia FM and Reed E: Platlnum-DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometry. Carcinogenesis 12: 1253-1258, 1991.
8. Chu G: Cellular responses to cisplatin. The roles of DNA binding proteins and DNA repair. J Biol Chem 269 (2): 787-790, 1994.
9. 2 formed in human plasma. Proc Natl Acad Sci 81: 1317-1321, 1984.
10. 2 controls metastasis of malignant melanoma cells. Nature (London) 282: 76-78, 1979.
11. 2. Prostaglandins 25: 47-54, 1983.
12. 2. Cancer Res 46: 3363-3366, 1986.
13. 2 in vitro and in vivo Cancer Res 46: 3538-3542, 1986.
14. 2 Biochemistry 29: 3760-3765, 1990.
15. Nayori R, Suzuki M: Organic synthesis of prostaglandins: Advancing biology. Science 259: 44-45, 1993.
16. ElAttar TMA and Virji AS: Inhibition of growth of oral squamous carcinoma cells by cyclopentenone prostaglandins. Prostaglandins Leukotrienes and Essential Fatty Acids. 56(6): 461-465, 1997.
17. Rheinwald JG and Beckett MA: Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res 41: 1657-1663, 1981 .
18. ElAttar TMA and Lin HS: Vitamin E succinate potentiates the inhibitory effect of prostaglandins on oral squamous carcinoma cell proliferation. Prostaglandins Leukotrienes and Essential Fatty Acids 52: 69-73, 1995.
19. 2 is cytotoxic in human malignancies and synergizes with both cisplatin and radiation. Cancer Res 56: 3866-3869, 1996.
20. 2 induces apoptosis in cells. Fed Eur Biochem Soc 321: 209-214, 1993.
21. Negishi M, Sugimoto Y, Ichikawa A: Prostanoid receptors and their biological actions. Prog Lipid Res 32: 417-434, 1993.
22. Narumiya S, Ohno K, Fujiwara M and Fukushima M: Site and mechanism of growth inhibition by prostaglandins. II. Temperature-dependent transfer of a cyclopentenone prostaglandin to nuclei. J Pharmacol Exp Ther 239: 506-571, 1986.
23. Ohno K, Fukushima M, Fujiwara M, Narumiya S: Induction of 68,000 dalton heat shock proteins by cyclopentenone prostaglandins. J Biol Chem 263: 19764-19770, 1988.
24. Kahn SH and Sorof S: Preferential binding of growth inhibitory prostaglandins by the target protein of a carcinogen. Proc Natl Acad Sci U.S.A. 87: 9401-9405, 1990.
25. Ishioka C, Kanamary R, Sato T: Inhibitory effects of prostaglandin A2 on c-myc expression and cell cycle progression in human leukemia cell line HL-60. Cancer Res 48: 2813-2818, 1988.
26. 2 results in elevated expression of GADD 153 mRNA. Exp Cell Res 199: 85-89, 1992.
27. Santoro MG: Heat shock proteins and virus replication: hsp 70s as mediators of antiviral effects of prostaglandins. Experientia (Basel) 50(11-12): 1039-1047, 1994.
28. Rossi A, Elia G and Santoro G: 2-Cyclopen-1-one, a new inducer of heat shock protein 70 with antiviral activity. J Biol Chem 277: 32192-32196, 1996.